GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (FRA:0JZ) » Definitions » YoY EBITDA Growth

Affluent Medical (FRA:0JZ) YoY EBITDA Growth : -2.22% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Affluent Medical's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -2.22%.

Affluent Medical's EBITDA per Share for the six months ended in Jun. 2024 was €-0.23.

Affluent Medical YoY EBITDA Growth Historical Data

The historical data trend for Affluent Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical YoY EBITDA Growth Chart

Affluent Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 20.84 28.66 -11.72 30.56 30.44

Affluent Medical Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.62 33.43 27.65 -2.22 46.22

Affluent Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Affluent Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.45--0.648)/ | -0.648 |
=30.56 %

Affluent Medical's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.23--0.225)/ | -0.225 |
=-2.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Affluent Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Affluent Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Affluent Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (FRA:0JZ) » Definitions » YoY EBITDA Growth
Comparable Companies
XPAR:ALCAR XPAR:ALMDT XPAR:ALNOV XPAR:ALBIO XPAR:ALDMS XPAR:ALIKO XPAR:ALIMP XPAR:ALBLU XPAR:ALTHE XPAR:ALSGD ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
AFME:France 0JZ:Germany
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Website
https://www.affluentmedical.com
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.

Affluent Medical Headlines

No Headlines